Progestin-only injectable contraception with depot medroxyprogesterone acetate (DMPA) has the potential to offer top-tier efficacy because it has a first-year failure rate of only 0.3% if used ...
Experts advise that a quality issue could pose risk for patients being treated for some reproductive-related healthcare needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback